Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia
Jonathan Goodfellow, BSc, MB, MRCPa,
Michael F. Bellamy, BSc, MB, MRCPa,
Mark W. Ramsey, DM, BMedSci, MRCPa,
Christopher J. H. Jones, MB, FRCP1,a and
Malcolm J. Lewis, MB, PhD, DSca
a Cardiovascular Sciences Research Group, University of Wales College of Medicine, Cardiff, United Kingdom

View larger version (14K):
[in a new window]
|
Figure 1 The effect of four months of treatment with placebo and omega-3 fatty acids on the following. A, Brachial artery blood flow (expressed as percent change from baseline) at: peak flow immediately after wrist cuff deflated, 1 min after cuff deflated and 3 min after 400 µg sublingual GTN. There were no significant differences between groups. B, Flow-mediated dilation expressed as absolute change (mm) from baseline diameter. There is a significant improvement within the omega-3 fatty acids group posttreatment (*p < 0.05) and when compared with placebo posttreatment (**p < 0.05). C, Glyceryl trinitrate-mediated dilation expressed as absolute change (mm) from baseline diameter. There were no significant differences between groups. Data are presented as mean ± SEM.
Solid bars = posttreatment; Open bars = pretreatment.
|
|
|